We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurre... Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. Its clinical-stage product candidates include Rilonacept, for the treatment of recurrent pericarditis, a debilitating inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody for the treatment of giant cell arteritis; Vixarelimab; and KPL-404. Show more
– ARCALYST® (rilonacept) Q3 2024 net product revenue of $112.2 million, representing 73% year-over-year growth –– ARCALYST 2024 expected net product revenue increased to $410 - $420 million ––...
– National campaign to elevate experiences from the recurrent pericarditis community and empower patients to seek care – LONDON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals...
LONDON, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, October 29...
LONDON, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company, has teamed up with National Hockey...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -6.095 | -21.7174416533 | 28.065 | 28.15 | 20.2552 | 490181 | 23.57236102 | CS |
4 | -2.51 | -10.2532679739 | 24.48 | 28.15 | 20.2552 | 322795 | 25.06634434 | CS |
12 | -3.23 | -12.8174603175 | 25.2 | 28.15 | 20.2552 | 364046 | 25.3527789 | CS |
26 | 1.83 | 9.08639523337 | 20.14 | 28.15 | 17.38 | 411166 | 23.20135192 | CS |
52 | 5.74 | 35.3666050524 | 16.23 | 28.15 | 14.12 | 417815 | 20.8028646 | CS |
156 | 7.93 | 56.4814814815 | 14.04 | 28.15 | 7.36 | 391850 | 15.99381578 | CS |
260 | 14.49 | 193.71657754 | 7.48 | 33 | 6.28 | 385758 | 16.31295873 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions